Back
Bicara Therapeutics Vs. RH Industry Stock Comparison
Buy
52
BCAX
Bicara Therapeutics
Last Price:
$12.45
Seasonality Move:
--
Sell
34
RH
RH
Last Price:
$225.25
Seasonality Move:
17.71%
Buy
52
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.35. The Score for BCAX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
-
RH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RH Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 47.45 | Sell |
Chaikin Money Flow: | 643187 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.29 - 14.39) | Buy |
Bollinger Bands (100): | (13.09 - 21.33) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -42.67 | Sell |
Relative Strength Index (14 RSI): | 18.28 | Sell |
Chaikin Money Flow: | -925315 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (281.17 - 399.29) | Sell |
Bollinger Bands (100): | (319.37 - 416.89) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.31 | Sell |
20-day SMA: | 13.54 | Sell |
50-day SMA: | 13.67 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 14 | Sell |
20-day EMA: | 13.7 | Sell |
50-day EMA: | 14.13 | Sell |
200-day EMA: | 11.12 | Buy |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 265.06 | Sell |
20-day SMA: | 323.51 | Sell |
50-day SMA: | 378.76 | Sell |
200-day SMA: | 320.99 | Sell |
8-day EMA: | 262.27 | Sell |
20-day EMA: | 309.83 | Sell |
50-day EMA: | 351.34 | Sell |
200-day EMA: | 335.58 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.69 per share, a decrease next quarter of $0.78 per share, a decrease this year of $2.07 per share, and an increase next year of $7.32 per share.
Bicara Therapeutics Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |